OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL

被引：48

作者：

BARNHART, JW ^{[1
]}

RYTTER, DJ ^{[1
]}

MOLELLO, JA ^{[1
]}

机构：

[1] DOW CHEM USA,DEPT HLTH & CONSUMER PROD,INDIANAPOLIS,IN 46268

来源：

LIPIDS | 1977年 / 12卷 / 01期

关键词：

D O I：

10.1007/BF02532968

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：29 / 33

页数：5

共 22 条

[1]

AMADOR E, 1963, CLIN CHEM, V9, P391

[2]

BARNHART JW, 1970, AM J CLIN NUTR, V23, P1229

[3]

BONNICHSEN R, METHODS ENZYMOLOGY, V2, P781

[4]

CARROLL NV, 1956, J BIOL CHEM, V220, P583

[5] EFFECT OF [4,4'-(ISOPROPYLIDENEDITHIO)BIS(2,6-DI-T-BUTYLPHENOL)] (DH-581) ON SERUM LIPIDS AND LIPOPROTEINS IN HUMAN SUBJECTS [J].

DRAKE, JW ;

BRADFORD, RH ;

MCDEARMON, M ;

FURMAN, RH .

METABOLISM, 1969, 18 (11) :916-+

[6]

GRUNDY SM, 1965, J LIPID RES, V6, P397

[7] LONG-TERM ORAL-ADMINISTRATION OF PROBUCOL [4,4'-(ISOPROPYLIDENEDITHIO)BIS (2,6-DI-T-BUTYLPHENOL)] (DH-581) IN MANAGEMENT OF HYPERCHOLESTEROLEMIA [J].

HARRIS, RS ;

GILMORE, HR ;

BRICKER, LA ;

KIEM, IM ;

RUBIN, E .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1974, 22 (04) :167-175

[8]

HENLY AA, 1957, ANALYST, V82, P286

[9]

KING J, 1960, J Med Lab Technol, V17, P1

[10]

KRITCHEVSKY D, 1971, P SOC EXP BIOL MED, V136, P1216

← 1 2 3 →